Oslo, 20 August 2019: Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), a
pharmaceutical company developing novel immunotherapies against cancer, invites
to a presentation of its first half 2019 results on Wednesday 21 August 2019.
The presentation by the company's management team will take place at Oslo Cancer
Cluster Innovation Park (Ullernchausséen 64) in Jónas Einarsson Auditorium (2nd
floor, entrance 2B) at 08:00 CET on Wednesday 21 August 2019.
The presentation can be followed as a live webcast (access through link
https://webtv.hegnar.no/presentation.php?webcastId=98044203) which will also be
available on our website. It will be possible to post questions during the
presentation through the webcast.
The report and presentation will also be available on the company website.
For further information, please see www.ultimovacs.com or contact:
Øyvind Kongstun Arnesen, CEO
email@example.com, +47 469 33810
Hans Vassgård Eid, CFO
firstname.lastname@example.org, +47 469 19822